• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小柴胡汤及其成分抗肝癌作用的研究进展。

Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents.

机构信息

Center for Traditional Chinese Medicine and Systems Biology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

出版信息

Evid Based Complement Alternat Med. 2013;2013:529458. doi: 10.1155/2013/529458. Epub 2013 Jun 18.

DOI:10.1155/2013/529458
PMID:23853661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3703324/
Abstract

Xiao Chai Hu Tang (XCHT), a compound formula originally recorded in an ancient Chinese medical book Shanghanlun, has been used to treat chronic liver diseases for a long period of time in China. Although extensive studies have been demonstrated the efficacy of this formula to treat chronic hepatitis, hepatic fibrosis, and hepatocarcinoma, how it works against these diseases still awaits full understanding. Here, we firstly present an overview arranging from the entire formula to mechanism studies of single herb in XCHT and their active components, from a new perspective of "separation study," and we tried our best to both detailedly and systematically organize the antihepatocarcinoma effects of it, hoping that the review will facilitate the strive on elucidating how XCHT elicits its antihepatocarcinoma role.

摘要

小柴胡汤(XCHT),一种最初记录在古代中医书籍《伤寒论》中的复方配方,在中国长期用于治疗慢性肝病。尽管广泛的研究已经证明了该配方治疗慢性肝炎、肝纤维化和肝癌的疗效,但它如何治疗这些疾病仍有待全面了解。在这里,我们首先从“分离研究”的新视角,从整个配方到 XCHT 中单味药及其活性成分的机制研究,综述了 XCHT 的抗肝癌作用,并尝试详细系统地组织 XCHT 的抗肝癌作用,希望这篇综述将有助于阐明 XCHT 发挥其抗肝癌作用的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/035aa16bf974/ECAM2013-529458.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/68a36351bb18/ECAM2013-529458.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/7e43e1d4e3c6/ECAM2013-529458.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/8ab7567ad7ff/ECAM2013-529458.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/4bbd028ea612/ECAM2013-529458.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/0e5c6aa00984/ECAM2013-529458.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/035aa16bf974/ECAM2013-529458.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/68a36351bb18/ECAM2013-529458.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/7e43e1d4e3c6/ECAM2013-529458.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/8ab7567ad7ff/ECAM2013-529458.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/4bbd028ea612/ECAM2013-529458.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/0e5c6aa00984/ECAM2013-529458.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46b8/3703324/035aa16bf974/ECAM2013-529458.006.jpg

相似文献

1
Current understanding on antihepatocarcinoma effects of xiao chai hu tang and its constituents.小柴胡汤及其成分抗肝癌作用的研究进展。
Evid Based Complement Alternat Med. 2013;2013:529458. doi: 10.1155/2013/529458. Epub 2013 Jun 18.
2
Understanding the polypharmacological anticancer effects of Xiao Chai Hu Tang via a computational pharmacological model.通过计算药理学模型理解小柴胡汤的多药抗癌作用。
Exp Ther Med. 2014 Jun;7(6):1777-1783. doi: 10.3892/etm.2014.1660. Epub 2014 Apr 2.
3
Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan's Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea.小柴胡汤干预伊立替康处置:小柴胡汤减轻伊立替康相关性腹泻的潜力。
Curr Cancer Drug Targets. 2019;19(7):551-560. doi: 10.2174/1568009618666181029153255.
4
Xiao-Chai-Hu Tang in treating model mice with D-galactosamine-induced liver injury.小柴胡汤治疗D-半乳糖胺诱导的肝损伤模型小鼠。
Afr J Tradit Complement Altern Med. 2012 Apr 2;9(3):405-11. doi: 10.4314/ajtcam.v9i3.16. eCollection 2012.
5
THE HERBAL MIXTURE XIAO-CHAI-HU TANG (XCHT) INDUCES APOPTOSIS OF HUMAN HEPATOCELLULAR CARCINOMA HUH7 CELLS AND .中药复方小柴胡汤(XCHT)诱导人肝癌Huh7细胞凋亡 并且 。 (你提供的原文似乎不太完整,翻译可能会有一定局限性。)
Afr J Tradit Complement Altern Med. 2017 Mar 1;14(3):231-241. doi: 10.21010/ajtcam.v14i3.25. eCollection 2017.
6
Xiao Chai Hu Tang for Peptic Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.小柴胡汤治疗消化性溃疡:随机对照试验的系统评价和Meta分析
Evid Based Complement Alternat Med. 2021 Apr 29;2021:6693677. doi: 10.1155/2021/6693677. eCollection 2021.
7
Insight into the mechanism of Xiao-Chai-Hu-Tang alleviates irinotecan-induced diarrhea based on regulating the gut microbiota and inhibiting Gut β-GUS.基于调节肠道菌群和抑制 Gut β-GUS,探讨小柴胡汤缓解伊立替康所致腹泻的作用机制。
Phytomedicine. 2023 Nov;120:155040. doi: 10.1016/j.phymed.2023.155040. Epub 2023 Aug 19.
8
Chemical and Absorption Signatures of Xiao Chai Hu Tang.小柴胡汤的化学及吸收特征
Rapid Commun Mass Spectrom. 2018 Mar 23. doi: 10.1002/rcm.8114.
9
Network pharmacology and bioinformatics approach to unravel the mechanism of Xiao-chai-hu-tang herbal formula in tinnitus treatment.基于网络药理学和生物信息学方法解析小柴胡汤治疗耳鸣的作用机制
Heliyon. 2024 Sep 10;10(18):e37584. doi: 10.1016/j.heliyon.2024.e37584. eCollection 2024 Sep 30.
10
Renal protective effect of xiao-chai-hu-tang on diabetic nephropathy of type 1-diabetic mice.小柴胡汤对 1 型糖尿病小鼠糖尿病肾病的肾脏保护作用。
Evid Based Complement Alternat Med. 2012;2012:984024. doi: 10.1155/2012/984024. Epub 2012 Mar 7.

引用本文的文献

1
The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19.中医药和《中国药典》在评估和治疗 COVID-19 中的作用。
Curr Pharm Des. 2024;30(14):1060-1074. doi: 10.2174/0113816128217263240220060252.
2
, : Toward the modernization of traditional Chinese medicine.迈向中医药现代化。
Front Neurosci. 2022 Nov 10;16:1057817. doi: 10.3389/fnins.2022.1057817. eCollection 2022.
3
SEAttle-based Research of Chinese Herbs for COVID-19 Study: A Whole Health Perspective on Chinese Herbal Medicine for Symptoms that may be Related to COVID-19.

本文引用的文献

1
[Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].[中药治疗肝癌患者经动脉化疗栓塞术副作用的系统评价与Meta分析]
Zhong Xi Yi Jie He Xue Bao. 2012 Dec;10(12):1341-62. doi: 10.3736/jcim20121204.
2
Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients.肝硬化患者肝细胞癌肝切除术的当前概念。
World J Gastroenterol. 2012 Nov 28;18(44):6398-408. doi: 10.3748/wjg.v18.i44.6398.
3
Activation of systemic antitumor immunity via TRAIL-induced apoptosis.
基于西雅图的中药治疗新冠肺炎研究:从整体健康角度看用于可能与新冠肺炎相关症状的中药。
Glob Adv Health Med. 2022 Jan 25;11:21649561211070483. doi: 10.1177/21649561211070483. eCollection 2022.
4
Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections.清瘟解热合剂对 SARS-CoV-2 和其他人类冠状病毒感染的广谱抗病毒和抗炎活性。
Phytomedicine. 2021 Dec;93:153808. doi: 10.1016/j.phymed.2021.153808. Epub 2021 Oct 18.
5
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.中医药治疗 COVID-19 和其他病毒感染:疗效和机制。
Pharmacol Ther. 2021 Sep;225:107843. doi: 10.1016/j.pharmthera.2021.107843. Epub 2021 Mar 31.
6
Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming.清肺排毒汤通过抗病毒、抗炎活性和代谢编程来预防 COVID-19 损伤。
Biomed Pharmacother. 2020 Sep;129:110281. doi: 10.1016/j.biopha.2020.110281. Epub 2020 May 25.
7
Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.小柴胡汤,一种草药,用于治疗慢性乙型肝炎。
Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD013090. doi: 10.1002/14651858.CD013090.pub2.
8
Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action.柴胡皂苷d通过p-STAT3/C/EBPβ信号通路抑制肝癌中的COX2:一种新的作用机制。
Front Pharmacol. 2019 May 29;10:623. doi: 10.3389/fphar.2019.00623. eCollection 2019.
9
Baicalein Exerts Anticancer Effect in Nasopharyngeal Carcinoma In Vitro and In Vivo.黄芩素在体外和体内对鼻咽癌具有抗癌作用。
Oncol Res. 2019 May 7;27(5):601-611. doi: 10.3727/096504018X15399945637736.
10
The Medicinal Plant Pair - - Metabolomics and Metallomics Analysis in a Model for Alcoholic Liver Injury.药用植物对——酒精性肝损伤模型中的代谢组学和金属组学分析
Front Pharmacol. 2019 Mar 20;10:254. doi: 10.3389/fphar.2019.00254. eCollection 2019.
通过TRAIL诱导的凋亡激活全身抗肿瘤免疫。
Oncoimmunology. 2012 Oct 1;1(7):1178-1180. doi: 10.4161/onci.20638.
4
Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians.在一家中国癌症医院中,癌症患者和医生对中医药疗法的利用和态度:一项调查。
Evid Based Complement Alternat Med. 2012;2012:504507. doi: 10.1155/2012/504507. Epub 2012 Oct 11.
5
Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.20(S)-人参皂苷 Rg3 通过 CHOP 介导的 DR5 上调增强 TRAIL 诱导的人肝癌细胞死亡敏感性。
Mol Cancer Ther. 2013 Mar;12(3):274-85. doi: 10.1158/1535-7163.MCT-12-0054. Epub 2012 Oct 10.
6
Antioxidant and Protective Effects of Bupleurum falcatum on the L-Thyroxine-Induced Hyperthyroidism in Rats.北柴胡对甲状腺素致大鼠甲亢的抗氧化及保护作用。
Evid Based Complement Alternat Med. 2012;2012:578497. doi: 10.1155/2012/578497. Epub 2012 Jul 25.
7
6-Shogaol induces apoptosis in human hepatocellular carcinoma cells and exhibits anti-tumor activity in vivo through endoplasmic reticulum stress.6-姜烯酚通过内质网应激诱导人肝癌细胞凋亡,并在体内显示抗肿瘤活性。
PLoS One. 2012;7(6):e39664. doi: 10.1371/journal.pone.0039664. Epub 2012 Jun 29.
8
Molecular mechanism inhibiting human hepatocarcinoma cell invasion by 6-shogaol and 6-gingerol.6-姜酚和 6-姜烯酚抑制人肝癌细胞侵袭的分子机制。
Mol Nutr Food Res. 2012 Aug;56(8):1304-14. doi: 10.1002/mnfr.201200173. Epub 2012 Jun 20.
9
Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.通过阻断 MEK-ERK 信号通路,黄酮类化合物黄芩素优先抑制肝癌。
Int J Oncol. 2012 Sep;41(3):969-78. doi: 10.3892/ijo.2012.1510. Epub 2012 Jun 6.
10
Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways.活性氧介导的人参皂苷 Rg3 和 Rh2 通过线粒体信号通路诱导肝癌细胞凋亡。
Food Chem Toxicol. 2012 Aug;50(8):2736-41. doi: 10.1016/j.fct.2012.05.027. Epub 2012 May 22.